5. Demonstrated Effectiveness

34%

27%

43%

Surgery patients avoiding any RBC transfusion

Phase II

VASCULAR

Phase II

CARDIAC

Phase III

GENERAL

Phase III

ORTHOPEDIC

59%

Source: Biopure Corporation Data on File

? 6 days

? 7 units

? 6 days

? 10 units

? 4 days

? 4 units

? 3 days

? 3 units

Previous slide

Next slide

Back to first slide

View graphic version